Data demonstrates survival benefit with the Impella RP Recover Right protocol
March 26, 2019
NEW ORLEANS, March 18, 2019 – Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies and the maker of the Impella RP heart pump, announces that survival data from the 18 month post-approval study of 42 Impella RP patients was presented at the https://accscientificsession.acc.org/ in New Orleans. The Impella RP is the only percutaneous technology with FDA PMA approval for right…
February 27, 2019
A pilot program using several clinical decision support tools in the outpatient setting to treat and educate stable ischemic heart disease patients has shown success in improving angina in these patients. Findings from the Florida Cardiovascular Quality Network study were presented at the American College of Cardiology’s Cardiovascular Summit in Orlando.
February 27, 2019
Comprehensive image and information management solution features new pediatric innovative workflow and integration with Philips Forcare for enhanced interoperability across health systems and hospitals.
February 26, 2019
Medtronic plc (NYSE:MDT) today announced the launch of its MyCareLink Heart(TM) mobile app to support the world’s first and only portfolio of pacemakers that can communicate directly with patients’ smartphones and tablets.
December 30, 2018
The first wearable blood pressure monitor comes in the form of a wrist watch and is an FDA-reviewed medical device.
December 29, 2018
IRVINE, Calif., Dec. 3, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced that the HemoSphere advanced hemodynamic monitoring platform has received U.S. Food and Drug Administration clearance for the Acumen suite of intelligent decision-support solutions.
December 20, 2018
SAN CARLOS, Calif. – December 11, 2018 – BioCardia, Inc. today announced its 510(k) submission for U.S. Food and Drug Administration (FDA) clearance of the AVANCE™ steerable introducer, designed for introducing various cardiovascular catheters into the heart, including via the left side of the heart through the interatrial septum.
November 30, 2018
Medtronic announced in October that it has received U.S. Food and Drug Administration (FDA) approval for the Valiant Navion™ thoracic stent graft system for the minimally invasive repair of all lesions of the descending thoracic aorta, including thoracic aortic aneurysms (TAA), blunt thoracic aortic injuries (BTAI), penetrating atherosclerotic ulcers (PAU), intramural hematomas (IMH), and aortic type B dissections (TBAD).
November 29, 2018
Abbott announced that the HeartMate 3™ Left Ventricular Assist Device (LVAD) has received U.S. Food and Drug Administration (FDA) approval as a destination therapy for people living with advanced heart failure. With the approval, physicians can now offer the HeartMate 3 system to patients not eligible for a transplant who will live with their device for the rest of their lives.
November 28, 2018
The American College of Cardiology, the American Heart Association and the Heart Rhythm Society today released a guideline for the evaluation and treatment of patients with bradycardia, or a slow heartbeat, and cardiac conduction disorders.